Evidence-Based Medicine Guidelines
Anti-VEGF for macular oedema secondary to central retinal vein occlusion
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Anti-VEGF for Macular Oedema Secondary to Central Retinal Vein Occlusion." Evidence-Based Medicine Guidelines, John Wiley & Sons, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/458242/all/_________Anti_VEGF_for_macular_oedema_secondary_to_central_retinal_vein_occlusion______.
Anti-VEGF for macular oedema secondary to central retinal vein occlusion. Evidence-Based Medicine Guidelines. John Wiley & Sons; 2025. https://evidence.unboundmedicine.com/evidence/view/EBMG/458242/all/_________Anti_VEGF_for_macular_oedema_secondary_to_central_retinal_vein_occlusion______. Accessed March 15, 2025.
Anti-VEGF for macular oedema secondary to central retinal vein occlusion. (2025). In Evidence-Based Medicine Guidelines. John Wiley & Sons. https://evidence.unboundmedicine.com/evidence/view/EBMG/458242/all/_________Anti_VEGF_for_macular_oedema_secondary_to_central_retinal_vein_occlusion______
Anti-VEGF for Macular Oedema Secondary to Central Retinal Vein Occlusion [Internet]. In: Evidence-Based Medicine Guidelines. John Wiley & Sons; 2025. [cited 2025 March 15]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/458242/all/_________Anti_VEGF_for_macular_oedema_secondary_to_central_retinal_vein_occlusion______.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Anti-VEGF for macular oedema secondary to central retinal vein occlusion
ID - 458242
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/458242/all/_________Anti_VEGF_for_macular_oedema_secondary_to_central_retinal_vein_occlusion______
PB - John Wiley & Sons
DB - Evidence Central
DP - Unbound Medicine
ER -
